Lauxera Capital Partners — Full Portfolio
15 tracked investments · listed companies and verified rows first
Matrix Req is AI-powered software for medical device companies to manage requirements, specifications, risks, and test cases with complete traceability and automated compliance checking across global regulatory standards.
AI & Machine LearningCloud ComputingEnterprise SoftwareHealthtechMedical DevicesSaaSKehl, DE
Yves Berquin(Co-founder)inWolfgang Huber(Co-founder)in
Reapplix develops advanced wound care products and therapeutics for clinical use.
BiotechHealthtechMedical DevicesDenmark, DK
Niels Erik Holm(Co-founder)Rasmus Lundquist(Chief Scientific Officer)in
Co-investorsSeed Capital Limited
Antaros Medical is a development partner to the pharmaceutical industry that uses medical imaging to provide evidence-based decision support during clinical drug development.
BiotechDigital HealthHealthtechMedical Devices
BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications.
BiotechDeep TechDigital HealthHealthtechMedical DevicesNew MaterialsStockholm, SE
Kristian Tryggvason(Founder and Board Member)inKarl Tryggvason
Co-investorsEuropean Investment Bank
HealthtechBoston, US
Bjoern von Siemens(Executive Officer, Director)inDennis Kogan(Executive Officer, Director)Filip Pintelon(Director)inWerner Zoellner(Director)Paul Summerside(Director)Timothy Lantz(Executive Officer)
Co-investorsHarmonix FundIntel CapitalOptum Ventures
Lifen provides digital tools for accessing and managing medical documents, serving patients and healthcare providers in France.
Digital HealthHealthtechSaaSParis, FR
Alexandre Huckert(Founder)inFranck Le Ouay(Founder)in
Co-investorsDaphniSerenaCreadevIdinvest Partners
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsSoftBank Vision FundEuropean Investment BankGilde HealthcareIrving InvestorsPura Vida InvestmentsT. Rowe Price
Natural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning.
Digital HealthFemTechMedical Devices
Dr. Elina Berglund Scherwitzl(Co-founder and CEO)inRaoul Scherwitzl(Co-founder)in
Co-investorsBonnier CapitalHeadlineHeadline Growth Management, LLCEQT VenturesPoint72 Ventures
OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.
BiotechHealthtechMedical DevicesOxford, GB
Prof. Peter Friend(Co-Founder)
Co-investorsAmadeus Capital PartnersBusiness Growth FundHealthQuest CapitalIntuitive VenturesLongwall Venture Partners LLPOxford University Innovation+1 more
Rubis Santé is a healthcare logistics and patient transport coordination platform designed for hospitals and medical facilities.
AI & Machine LearningDigital HealthHealthtechLogistics & Supply ChainSaaS
Jérémy Wies(Founder)in
Veranex provides multi-disciplinary services to medical device and healthcare companies, supporting them from concept through commercialization of medical innovations.
BiotechDigital HealthHealthtechMedical DevicesRaleigh, US
Patrick K. Donnelly(Founder)inMegan Osorio(Chief Executive Officer)inJose Pablo Morales(Chief Medical Officer)inBeth Moeller(Chief Commercial Officer)inDavid Dockhorn(Chief Operating Officer)inManasi Ramanna(Chief Financial Officer)in
.jpg)
Co-investorsSummit PartnersAccelmed Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AcandisOspiQuantiumportalVerdot
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.